These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR; Kiely P; Keller AJ Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258 [TBL] [Abstract][Full Text] [Related]
9. The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice. Bayer WL; Tegtmeier GE; Barbara JA Clin Haematol; 1984 Feb; 13(1):253-69. PubMed ID: 6327132 [No Abstract] [Full Text] [Related]
10. [Clinical aspects and risk factors in posttransfusion hepatitis]. Realdi G; Tremolada F; Chiappetta F; Antona C; Noventa F; Loreggian M; Chemello L; Alberti A Ric Clin Lab; 1984; 14 Suppl 1():17-35. PubMed ID: 6330858 [No Abstract] [Full Text] [Related]
11. [Cytomegalovirus infection after transfusion]. Kai S; Hara H Rinsho Byori; 1991 Mar; Suppl 88():176-82. PubMed ID: 1649928 [No Abstract] [Full Text] [Related]